ConductScience.org, home

Paper39109285

Efficacy and safety of radical cystectomy with ileal conduit for muscle-invasive bladder cancer in the elderly: a multicenter retrospective study.

Zhang H and 5 others. Front Oncol, 2024. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Efficacy and safety of radical cystectomy with ileal conduit for muscle-invasive bladder cancer in the elderly: a multicenter retrospective study. Papers, record 39109285. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39109285

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficacy and safety of radical cystectomy with ileal conduit for muscle-invasive bladder cancer in the elderly: a multicenter retrospective study.
PubMed
Journal
Front Oncol
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.36, provisional
iCite
Revised in PubMed
2024-08-08
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang HHeqian
2Li AAnrui
3Wang WWentao
4Xu SSonglin
5Li CChangfu
6Teng LLichen

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111490250Radical cystectomy is safe in elderly patients at high risk.J Urol2001https://conductscience.org/library/papers/11490250PubMed
21598671Proposed classification of complications of surgery with examples of utility in cholecystectomy.Surgery1992https://conductscience.org/library/papers/1598671PubMed
334950268Age and risk of major complications in patients undergoing radical cystectomy for muscle invasive bladder cancer.Wideochir Inne Tech Maloinwazyjne2021https://conductscience.org/library/papers/34950268PubMed
432504291Health-related quality of life overview after different curative treatment options in muscle-invasive bladder cancer: an umbrella review.Qual Life Res2020https://conductscience.org/library/papers/32504291PubMed
538336579Robot-assisted Radical Cystectomy with Totally Intracorporeal Urinary Diversion Versus Open Radical Cystectomy: 3-Year Outcomes from a Randomised Controlled Trial.Eur Urol2024https://conductscience.org/library/papers/38336579PubMed
638673693
Comparative Outcomes of Open Radical Cystectomy vs. Robot-Assisted Approaches with Intracorporeal and Extracorporeal Urinary Diversion: A Meta-Analysis and Network Meta-Analysis of Perioperative and Quality of Life Outcomes.
J Clin Med2024https://conductscience.org/library/papers/38673693PubMed
729329898[Prognostic of older age for patients with invasive-muscle-bladder cancer and treated by radical cystectomy].Prog Urol2018https://conductscience.org/library/papers/29329898PubMed
828478043Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review.Eur Urol2018https://conductscience.org/library/papers/28478043PubMed
915273542Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.Ann Surg2004https://conductscience.org/library/papers/15273542PubMed
1034986007Open Radical Cystectomy versus Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Early Outcomes of a Single-Center Randomized Controlled Trial.J Urol2022https://conductscience.org/library/papers/34986007PubMed
1136918330Correlation of Clinician- and Patient-Reported Outcomes in the BC2001 Trial.Clin Oncol (R Coll Radiol)2023https://conductscience.org/library/papers/36918330PubMed
1230207593Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2018https://conductscience.org/library/papers/30207593PubMed
1337932689Comparison of 3 and 4 cycles of neoadjuvant gemcitabine and cisplatin for muscle-invasive bladder cancer: a systematic review and meta-analysis.BMC Cancer2023https://conductscience.org/library/papers/37932689PubMed
1419481861Complications following radical cystectomy for bladder cancer in the elderly.Eur Urol2009https://conductscience.org/library/papers/19481861PubMed
1531326314Factors influencing ICU admission and associated outcome in patients undergoing radical cystectomy with enhanced recovery pathway.Urol Oncol2019https://conductscience.org/library/papers/31326314PubMed
1620461386The modified Clavien classification system: a standardized platform for reporting complications in transurethral resection of the prostate.World J Urol2011https://conductscience.org/library/papers/20461386PubMed
1737470427Surgical outcomes of robot-assisted radical cystectomy in octogenarian or older patients: A Japanese nationwide study.Int J Urol2023https://conductscience.org/library/papers/37470427PubMed
1838238117Age related trends in the utilization of neoadjuvant chemotherapy for muscle invasive bladder cancer.Urol Oncol2024https://conductscience.org/library/papers/38238117PubMed
1935011876
Evaluation of Functional Outcomes and Quality of Life in Elderly Patients (>75 y.o.) Undergoing Minimally Invasive Radical Cystectomy with Single Stoma Ureterocutaneostomy vs. Bricker Intracorporeal Ileal Conduit Urinary Diversion.
J Clin Med2021https://conductscience.org/library/papers/35011876PubMed
2035367155Long-term Health-related Quality of Life (HRQOL) After Radical Cystectomy and Urinary Diversion - A Propensity Score-matched Analysis.Clin Genitourin Cancer2022https://conductscience.org/library/papers/35367155PubMed

See all 25 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
41230143
A log odds of positive lymph nodes (LODDS)-based nomogram for survival prediction in elderly bladder cancer patients after radical cystectomy: development and validation using SEER and Chinese cohorts.
Transl Androl Urol2025https://conductscience.org/library/papers/41230143PubMed
40843354IRE1α modulates M1 oncolytic virus sensitivity via ER stress regulation in bladder cancer.Cancer Drug Resist2025https://conductscience.org/library/papers/40843354PubMed
39650069
Correlation analysis of preoperative renal insufficiency with major complications in patients who received a radical cystectomy and pelvic lymph node dissection: results of a retrospective observational analysis from a single center.
Front Oncol2024https://conductscience.org/library/papers/39650069PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39109285

GET https://conductscience.org/api/papers/v1/39109285/references?page=2